<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> exhibit higher DNA damage and increased risk of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, mechanisms underlying the association between DNA damage and development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> are not understood </plain></SENT>
<SENT sid="2" pm="."><plain>We sought to link peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PPARGC1A), a master transcriptional regulator of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> oxidative phosphorylation and cellular energy metabolism, with DNA damage, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: We measured DNA damage as urinary 8-hydroxydeoxyguanosine (8-OHdG) concentration and examined the relationship between nine PPARGC1A genetic variants, DNA damage, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and self-reported <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> in 959 participants of the Boston Puerto Rican Health Study </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: With respect to urinary 8-OHdG, PPARGC1A variants showed significant association, and PPARGC1A haplotypes exhibited significant association after correction for multiple testing </plain></SENT>
<SENT sid="5" pm="."><plain>Two independent PPARGC1A variants associated significantly with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (odds ratios [ORs] 1.35 and 2.46; P = 0.045 and &lt;0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Carriers of minor alleles of two other PPARGC1A variants, both in strong linkage disequilibrium and associated with lower DNA damage, showed lower prevalence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (ORs 0.53 and 0.65; P = 0.030 and 0.175) </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, we found that physical activity correlated negatively with DNA damage </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: It is plausible that low physical activity combined with risk haplotyes contribute to the high prevalence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in this population </plain></SENT>
<SENT sid="9" pm="."><plain>We propose that PPARGC1A influences development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> via DNA damage </plain></SENT>
<SENT sid="10" pm="."><plain>Increasing physical activity, which induces PPARGC1A expression, is a potential strategy to slow DNA damage, thereby decreasing the risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> for individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>